46
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Gannex is dedicated to the R&D and commercialization of new drugs in the field of NASH.
Jinzi Wu: Founder, Chief Executive Officer
Ascletis
About the Company
Gannex is dedicated to the R&D and commercialization of new drugs in the field of NASH. Gannex has three clinical-stage drug candidates against three different targets — FASN, THR-β, and FXR — and three combination therapies.
Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma.
